IL141562A0 - Particulate compositions for pulmonary delivery and methods for the preparation thereof - Google Patents

Particulate compositions for pulmonary delivery and methods for the preparation thereof

Info

Publication number
IL141562A0
IL141562A0 IL14156299A IL14156299A IL141562A0 IL 141562 A0 IL141562 A0 IL 141562A0 IL 14156299 A IL14156299 A IL 14156299A IL 14156299 A IL14156299 A IL 14156299A IL 141562 A0 IL141562 A0 IL 141562A0
Authority
IL
Israel
Prior art keywords
preparation
methods
pulmonary delivery
particulate compositions
particulate
Prior art date
Application number
IL14156299A
Original Assignee
Inhale Therapeutic Syst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inhale Therapeutic Syst filed Critical Inhale Therapeutic Syst
Publication of IL141562A0 publication Critical patent/IL141562A0/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Otolaryngology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
IL14156299A 1998-09-14 1999-09-13 Particulate compositions for pulmonary delivery and methods for the preparation thereof IL141562A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10016398P 1998-09-14 1998-09-14
PCT/US1999/021109 WO2000015262A1 (en) 1998-09-14 1999-09-13 Dry powder active agent pulmonary delivery

Publications (1)

Publication Number Publication Date
IL141562A0 true IL141562A0 (en) 2002-03-10

Family

ID=22278404

Family Applications (2)

Application Number Title Priority Date Filing Date
IL14156299A IL141562A0 (en) 1998-09-14 1999-09-13 Particulate compositions for pulmonary delivery and methods for the preparation thereof
IL141562A IL141562A (en) 1998-09-14 2001-02-21 Particulate compositions for pulmonary delivery and methods for the preparation thereof

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL141562A IL141562A (en) 1998-09-14 2001-02-21 Particulate compositions for pulmonary delivery and methods for the preparation thereof

Country Status (44)

Country Link
EP (1) EP1117442A1 (en)
JP (1) JP2002524535A (en)
KR (1) KR20010075063A (en)
CN (1) CN1317977A (en)
AP (1) AP1374A (en)
AR (1) AR022090A1 (en)
AU (1) AU753014B2 (en)
BG (1) BG105430A (en)
BR (1) BR9913722A (en)
CA (1) CA2343920A1 (en)
CO (1) CO5130023A1 (en)
CZ (1) CZ2001829A3 (en)
DZ (1) DZ2892A1 (en)
EA (1) EA003476B1 (en)
EE (1) EE200100151A (en)
GE (1) GEP20043257B (en)
GT (1) GT199900156A (en)
HK (1) HK1042231A1 (en)
HN (1) HN1999000159A (en)
HR (1) HRP20010189A2 (en)
HU (1) HUP0103837A3 (en)
ID (1) ID28845A (en)
IL (2) IL141562A0 (en)
IS (1) IS5878A (en)
LT (1) LT4897B (en)
LV (1) LV12658B (en)
MA (1) MA25590A1 (en)
MY (1) MY129282A (en)
NO (1) NO20011251L (en)
NZ (1) NZ510168A (en)
OA (1) OA11781A (en)
PA (1) PA8481901A1 (en)
PE (1) PE20001061A1 (en)
PL (1) PL195574B1 (en)
SA (1) SA99200718B1 (en)
SK (1) SK3442001A3 (en)
TN (1) TNSN99173A1 (en)
TR (1) TR200101182T2 (en)
TW (1) TWI226248B (en)
UA (1) UA76085C2 (en)
UY (1) UY25711A1 (en)
WO (1) WO2000015262A1 (en)
YU (1) YU24201A (en)
ZA (1) ZA200101995B (en)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4874483B2 (en) 1999-06-09 2012-02-15 ロバート イー. シーバース Supercritical fluid assisted nebulization and bubble drying
US6475468B2 (en) * 2001-02-15 2002-11-05 Aeropharm Technology Incorporated Modulated release particles for aerosol delivery
JP2005503425A (en) * 2001-05-24 2005-02-03 アレックザ モレキュラー デリヴァリー コーポレイション Delivery of drug ester by the prescribed inhalation route
EG24184A (en) * 2001-06-15 2008-10-08 Otsuka Pharma Co Ltd Dry powder inhalation system for transpulmonary
US7759506B2 (en) 2002-02-25 2010-07-20 Diffusion Pharmaceuticals Llc Bipolar trans carotenoid salts and their uses
JP2005518453A (en) 2002-02-25 2005-06-23 ディフュージョン・ファーマシューティカルズ・エルエルシー Bipolar trans carotenoid salts and their use
AU2003232081B2 (en) * 2002-07-03 2009-02-05 Brandeis University Central airway administration for systemic delivery of therapeutics
CA2511385A1 (en) * 2002-12-19 2004-07-22 Pharmacia Corporation Non-hygroscopic formulation comprising a hydroscopic drug
DE10338403A1 (en) * 2003-08-18 2005-03-17 Boehringer Ingelheim Pharma Gmbh & Co. Kg Powder formulation containing the CGRP antagonist 1- [N 2 - [3,5-dibromo-N - [[4- (3,4-dihydro-2 (1 H) -oxoquinazolin-3-yl] -1-piperidinyl] carbonyl] -D-tyrosyl] -L-lysyl] -4- (4-pyrindinyl) piperazine, process for its preparation and its use as inhalant
GB0327723D0 (en) * 2003-09-15 2003-12-31 Vectura Ltd Pharmaceutical compositions
US20070020299A1 (en) 2003-12-31 2007-01-25 Pipkin James D Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid
AU2005237523A1 (en) 2004-04-23 2005-11-10 Cydex Pharmaceuticals, Inc. DPI formulation containing sulfoalkyl ether cyclodextrin
EP2540696B1 (en) 2005-02-24 2020-01-01 Diffusion Pharmaceuticals LLC Trans carotenoids, formulation and uses
CN101171023A (en) * 2005-03-09 2008-04-30 小野药品工业株式会社 Particle and preparation containing the particle
DK2952197T3 (en) 2005-10-26 2017-08-07 Cydex Pharmaceuticals Inc SULPHALYCYLETER CYCLE CODE EXTRACTION COMPOSITION AND PROCEDURE FOR PREPARING THEREOF
US7629331B2 (en) 2005-10-26 2009-12-08 Cydex Pharmaceuticals, Inc. Sulfoalkyl ether cyclodextrin compositions and methods of preparation thereof
WO2008021451A2 (en) * 2006-08-14 2008-02-21 Aktiv-Dry Llc Human-powered dry powder inhaler and dry powder inhaler compositions
EP2095812A4 (en) * 2006-10-25 2011-07-13 Dainippon Sumitomo Pharma Co Granular preparation prevented from caking
EP1925295A1 (en) * 2006-11-22 2008-05-28 Boehringer Ingelheim Pharma GmbH & Co. KG Stable powder formulation containing a new antichinolinergic agent
KR101570131B1 (en) 2007-04-13 2015-11-18 디퓨젼 파마슈티컬즈 엘엘씨 Use of Bipolar Trans Carotenoids as a Pretreatment and in the Treatment of Peripheral Vascular Disease
JP2011502125A (en) 2007-10-31 2011-01-20 ディフュージョン・ファーマシューティカルズ・エルエルシー A new class of treatments that promote small molecule diffusion
PL2432502T3 (en) 2009-05-20 2018-05-30 Aeras Stable, spray dried, immunogenic, viral compositions
EP2445339B1 (en) 2009-06-22 2019-08-07 Diffusion Pharmaceuticals LLC Diffusion enhancing compound and its use with a thrombolytic
CN105287473A (en) 2010-06-02 2016-02-03 扩散药品有限公司 Oral formulations of bipolar trans carotenoids and uses thereof
RU2650636C2 (en) 2012-05-03 2018-04-16 Янссен Сайенсиз Айрлэнд Юси Polyinosinic-polycytidylic acid (poly(i:c)) formulations for the treatment of upper respiratory tract infections
BR112015010601B1 (en) * 2012-11-09 2022-07-19 Civitas Therapeutics, Inc. PHARMACEUTICAL COMPOSITION AND USE OF THE COMPOSITION
US20180043585A9 (en) * 2013-09-20 2018-02-15 Virginia Commonwealth University Delivery of particles using hygroscopic excipients
EP3212212B1 (en) 2014-10-31 2020-09-23 Monash University Powder formulation
WO2017165667A1 (en) 2016-03-24 2017-09-28 Diffusion Pharmaceuticals Llc Use of bipolar trans carotenoids with chemotherapy and radiotherapy for treatment of cancer
US20220378727A1 (en) * 2021-05-14 2022-12-01 The University Of Hong Kong Dry powder formulations of tamibarotene for pulmonary and intranasal delivery

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3155573A (en) * 1958-05-06 1964-11-03 Benger Lab Ltd Inhalant composition and method of making same
ES2177544T3 (en) * 1992-06-12 2002-12-16 Teijin Ltd ULTRAFININE POWDER TO INHALATE AND METHOD FOR PREPARATION.
US6524557B1 (en) * 1994-12-22 2003-02-25 Astrazeneca Ab Aerosol formulations of peptides and proteins
US5874064A (en) 1996-05-24 1999-02-23 Massachusetts Institute Of Technology Aerodynamically light particles for pulmonary drug delivery
WO1998031346A1 (en) * 1997-01-16 1998-07-23 Massachusetts Institute Of Technology Preparation of particles for inhalation
US6086376A (en) * 1998-01-30 2000-07-11 Rtp Pharma Inc. Dry aerosol suspension of phospholipid-stabilized drug microparticles in a hydrofluoroalkane propellant

Also Published As

Publication number Publication date
AP2001002093A0 (en) 2001-03-31
BG105430A (en) 2001-12-29
WO2000015262A1 (en) 2000-03-23
ZA200101995B (en) 2002-03-11
CO5130023A1 (en) 2002-02-27
AP1374A (en) 2005-02-28
IS5878A (en) 2001-03-05
AR022090A1 (en) 2002-09-04
EA003476B1 (en) 2003-06-26
YU24201A (en) 2003-08-29
ID28845A (en) 2001-07-05
CN1317977A (en) 2001-10-17
EA200100300A1 (en) 2001-10-22
KR20010075063A (en) 2001-08-09
GEP20043257B (en) 2004-06-25
LV12658A (en) 2001-05-20
IL141562A (en) 2007-07-24
HK1042231A1 (en) 2002-08-09
SA99200718B1 (en) 2006-11-04
PE20001061A1 (en) 2000-10-08
EP1117442A1 (en) 2001-07-25
MA25590A1 (en) 2002-12-31
LT2001021A (en) 2001-11-26
MY129282A (en) 2007-03-30
HUP0103837A3 (en) 2002-11-28
AU753014B2 (en) 2002-10-03
BR9913722A (en) 2001-05-29
UA76085C2 (en) 2006-07-17
GT199900156A (en) 2001-03-07
SK3442001A3 (en) 2001-11-06
NO20011251L (en) 2001-04-17
LT4897B (en) 2002-02-25
CZ2001829A3 (en) 2001-09-12
UY25711A1 (en) 1999-11-17
NZ510168A (en) 2003-09-26
DZ2892A1 (en) 2003-12-15
NO20011251D0 (en) 2001-03-13
JP2002524535A (en) 2002-08-06
EE200100151A (en) 2002-06-17
AU6039799A (en) 2000-04-03
PA8481901A1 (en) 2002-04-25
PL195574B1 (en) 2007-10-31
TWI226248B (en) 2005-01-11
CA2343920A1 (en) 2000-03-23
PL346768A1 (en) 2002-02-25
HUP0103837A2 (en) 2002-05-29
LV12658B (en) 2001-09-20
HRP20010189A2 (en) 2005-04-30
HN1999000159A (en) 1999-11-11
OA11781A (en) 2005-07-26
TR200101182T2 (en) 2001-09-21
TNSN99173A1 (en) 2005-11-10

Similar Documents

Publication Publication Date Title
IL141562A0 (en) Particulate compositions for pulmonary delivery and methods for the preparation thereof
IL138280A0 (en) 20-KETO-11β-ARYLSTERIODS, PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME AND METHODS FOR THE PREPARATION THEREOF
EP1079812A4 (en) Novel particulate formulations
EP1176948A4 (en) Anti-nausea compositions and methods
IL136938A0 (en) 11β-HALOGEN-7α-SUBSTITUTED ESTRATRIENES, PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME AND METHODS FOR THE PREPARATION THEREOF
IL143799A0 (en) Phenoxyphenyl derivatives and pharmaceutical compositions containing the same
HUP0400887A3 (en) Glycopeptide derivatives and pharmaceutical compositions containing the same
HUP0202762A3 (en) Solid lipid compositions, process for their preparation and use thereof
AP2000002010A0 (en) Novel pharmaceutical compositions for treating and saving and the methods for the preparation thereof
PL347497A1 (en) Compositions and methods for preparing dispersions and methods for using the dispersions
EP1056456A4 (en) R-lansoprazole compositions and methods
HUP0102215A3 (en) Benzoylpyridazines, pharmaceutical compositions containing the same and process for their preparation
PL352159A1 (en) Pharmaceutical compositions containing antibody against the fas
EP1056457A4 (en) S-lansoprazole compositions and methods
ZA955781B (en) New chemical compound the preparation thereof and its use in pharmaceutical compositions
HUP0104852A3 (en) Oktahydro-pyrido-pyrazine derivatives and pharmaceutical compositions containing the same and their use
GB9824225D0 (en) Speckle particles and compositions containing the speckle particles
GB9811168D0 (en) Direct hair-colouring compositions and the use thereof
EP1073333A4 (en) S-rabeprazole compositions and methods
HUP0105028A3 (en) Compositions having improved stability and process for their preparation
HUP0104834A3 (en) Sulphonyloxazolamines, their use, pharmaceutical compositions containing them and their preparation
EP1080225A4 (en) Compositions and methods for the pulmonary delivery of nucleic acids
EP1234869A4 (en) Cleaning composition and method for preparing the same
GB9803521D0 (en) New compounds and pharmaceutical compositions thereof
HUP0104544A3 (en) New pharmaceutical composition and the process for its preparation

Legal Events

Date Code Title Description
FF Patent granted
MM9K Patent not in force due to non-payment of renewal fees